258 related articles for article (PubMed ID: 23552630)
1. Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities.
Wasif N; Smith CA; Tamurian RM; Christensen SD; Monjazeb AM; Martinez SR; Canter RJ
JAMA Surg; 2013 Jul; 148(7):632-9. PubMed ID: 23552630
[TBL] [Abstract][Full Text] [Related]
2. Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma.
Wasif N; Tamurian RM; Christensen S; Do L; Martinez SR; Chen SL; Canter RJ
Ann Surg Oncol; 2012 Feb; 19(2):504-10. PubMed ID: 21769468
[TBL] [Abstract][Full Text] [Related]
3. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty.
Wasif N; Ye X; Giuliano AE
Ann Surg Oncol; 2009 Sep; 16(9):2442-9. PubMed ID: 19506955
[TBL] [Abstract][Full Text] [Related]
4. Current trials and new aspects in soft tissue sarcoma of adults.
Issels RD; Schlemmer M
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
[TBL] [Abstract][Full Text] [Related]
5. Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey.
Rothermundt C; Fischer GF; Bauer S; Blay JY; Grünwald V; Italiano A; Kasper B; Kollár A; Lindner LH; Miah A; Sleijfer S; Stacchiotti S; Putora PM
Oncologist; 2018 Apr; 23(4):461-467. PubMed ID: 29192019
[TBL] [Abstract][Full Text] [Related]
6. Patient surveillance after treatment for soft-tissue sarcoma.
Johnson FE; Sakata K; Sarkar S; Audisio RA; Kraybill WG; Gibbs JF; Beitler AL; Virgo KS
Int J Oncol; 2011 Jan; 38(1):233-9. PubMed ID: 21109945
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of margin width for extremity and trunk sarcoma.
McKee MD; Liu DF; Brooks JJ; Gibbs JF; Driscoll DL; Kraybill WG
J Surg Oncol; 2004 Feb; 85(2):68-76. PubMed ID: 14755506
[TBL] [Abstract][Full Text] [Related]
9. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
10. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
[TBL] [Abstract][Full Text] [Related]
11. Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study.
Yoneda Y; Kunisada T; Naka N; Nishida Y; Kawai A; Morii T; Takeda K; Hasei J; Yamakawa Y; Ozaki T;
Eur J Surg Oncol; 2014 Jan; 40(1):49-54. PubMed ID: 24075825
[TBL] [Abstract][Full Text] [Related]
12. Adult Soft-Tissue Sarcomas of the Extremities.
Bickels J; Malawer MM
J Bone Joint Surg Am; 2022 Feb; 104(4):379-389. PubMed ID: 34780385
[TBL] [Abstract][Full Text] [Related]
13. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
Kim SP; Tilburt JC; Karnes RJ; Ziegenfuss JY; Han LC; Shah ND; Frank I; Smaldone MC; Gross CP; Yu JB; Trinh QD; Sun M; O'Malley RL; Nguyen PL
Urology; 2013 Oct; 82(4):807-12. PubMed ID: 23910088
[TBL] [Abstract][Full Text] [Related]
14. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
Halperin EC; Hutchison P; Barrier RC
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
[TBL] [Abstract][Full Text] [Related]
15. [Surgical aspects in the multidisciplinary treatment of soft tissue sarcomas].
Röhrborn A; Röher HD
Praxis (Bern 1994); 1998 Aug; 87(34):1050-60. PubMed ID: 9757788
[TBL] [Abstract][Full Text] [Related]
16. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant regional irradiation after breast-conserving therapy for early stage breast cancer: a survey of canadian radiation oncologists.
Clavel S; Roy I; Carrier JF; Rousseau P; Fortin MA
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):39-45. PubMed ID: 19945833
[TBL] [Abstract][Full Text] [Related]
18. The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists.
Naumann RW; Higgins RV; Hall JB
Gynecol Oncol; 1999 Oct; 75(1):4-9. PubMed ID: 10502417
[TBL] [Abstract][Full Text] [Related]
19. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS
Cancer; 2003 May; 97(10):2544-53. PubMed ID: 12733154
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of treatment patterns among recurrent/metastatic soft tissue sarcoma patients who consulted medical oncologists in Japan.
Nakano K; Ae K; Matsumoto S; Takahashi S
J Orthop Sci; 2019 Nov; 24(6):1081-1087. PubMed ID: 31447093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
